CTRI/2018/09/015735进行中（未招募）未知
A randomized, single blind, parallel group, controlled clinical study to evaluate the efficacy of investigational product versus 0.1% adapelene in patients with acne vulgaris - ACNE
Atrimed Pharmaceuticals Pvt Ltd0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age group 11 yrs. and 30 yrs.
- •2. Both genders
- •3. Patients with inflammatory and non-inflammatory papules, open and closed comedones with few pustules present over the skin.
- •4. AGSS score more than 1
- •5. Count lesion of more than 10
- •6. Lesion to be present for not less than 3 months (recurrent lesions are included)
- •7. Able to give informed consent. For patients younger than 18 years old, representatives (parents/guardians) are required to provide informed consent and the same will be documented.
排除标准
- •1. Subjects on any other medication or cosmetics
- •2. Subjects using other anti-acne medications in the last 30 days before study
- •3. Patients with history of allergy to topical antibiotics
- •4. Pregnant women, those who may be pregnant, lactating women, and women who hope to become pregnant during the study period
- •5. Patients who had participated in other clinical studies within 3 months of the start of the study
- •6. Subjects who have any clinically significant allergic disease at the time of first examination or unwilling to enter into the study because of recent drug allergy.
- •7. History or presence of any debilitating disease like cancer, RA, TB etc.
- •8. Patients on OCP, antibiotics.
- •9. Patients with cystic acne and acne rosacea.
- •10. Patients on MAOI, ant- epileptics treatment, lithium.
- •11. PCOD / Underlying endocrine disease.
- •12. Patients with nodulocystic acne and acne fulminans.
- •13. Patients on steroids and ATT.
研究者
相似试验
尚未招募
2 期
Clinical study of Unani drug in comparison to conventional drug in the treatment of vitiligo (white patches)CTRI/2019/04/018669Central Research Institute of Unani Medicine
进行中（未招募）
不适用
A randomized, double-blind, parallel group, single-dose study of the efficacy of lidocaine 8 mg + cetylpyridinium chloride (CPC) 2 mg fixed combination lozenges on sore throat pain intensity compared to Mebucaine CL lozenges (containing lidocaine 1 mg and CPC 2 mg) in subjects with sore throat due to upper respiratory tract infectioSore throat due to upper respiratory tract infection(Planned indication for approval:Local antiseptic and analgesic treatment of sore throat and minor infections of the mouth.Relief of pain as well as irritation associated with these conditions in adults and adolescents aged 12 years and above.)MedDRA version: 12.1Level: LLTClassification code 10041367Term: Sore throatMedDRA version: 12.1Level: LLTClassification code 10068319Term: Oropharyngeal painEUCTR2010-021653-39-DEovartis Consumer Health S.A.
招募中
4 期
A clinical trial to study the effect of light meal on Aliskiren (300mg) in patients with high blood pressureCTRI/2009/091/000287ovartis Healthcare Pvt. Ltd.
进行中（未招募）
不适用
A randomized, double-blind, parallell-group, controlled study of topical pentane-1,5-diol hydrogel in patients with impetigoImpetigoEUCTR2005-000808-14-SEAmbria Dermatology88
进行中（未招募）
不适用
A randomised, parallel group, single blind, multicentre, 9-month, phase IV study in a primary care setting, comparing treatment guided by clinical symptoms and signs and NT-proBNP vs treatment guided by clinical symptoms and signs alone, in patients with heart failure and left ventricular systolic dysfunction. - SIGNAL HFHeart FailureEUCTR2006-001259-36-SEAstraZeneca AB250